Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 11;10(5):559.
doi: 10.3390/antibiotics10050559.

Phage Therapy in Livestock and Companion Animals

Celia Ferriol-González  1 , Pilar Domingo-Calap  1   2
Affiliations
Review

Phage Therapy in Livestock and Companion Animals

Celia Ferriol-González et al. Antibiotics (Basel). .

Abstract

The irrational use of antibiotics has led to a high emergence of multi-drug resistant (MDR) bacteria. The traditional overuse of antibiotics in the animal feed industry plays a crucial role in the emergence of these pathogens that pose both economic and health problems. In addition, antibiotics have also recently experienced an increase to treat companion animal infections, promoting the emergence of MDR bacteria in pets, which can reach humans. Phages have been proposed as an alternative for antibiotics for the treatment of livestock and companion animal infections due to their multiple advantages as adaptative drugs, such as their ability to evolve, to multiply at the site of infections, and their high specificity. Moreover, phage-derived enzymes may also be an interesting approach. However, the lack of regulation for this type of pharmaceutical hinders its potential commercialization. In this review, we summarize the main recent studies on phage therapy in livestock and companion animals, providing an insight into current advances in this area and the future of treatments for bacterial infections.

Keywords: antibiotics; antimicrobial resistance; phage therapy; veterinary medicine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Main differences between phages’ and antibiotics’ action against pathogenic bacteria; Phages are able to multiply in the site of infection, unlike antibiotics. Phages are able to evolve with bacteria while antibiotics are static structures. Phages are highly specific in their targets while antibiotics are generalists.
See this image and copyright information in PMC

References

    1. Czaplewski L., Bax R., Clokie M., Dawson M., Fairhead H., Fischetti V.A., Foster S., Gilmore B.F., Hancock R.E.W., Harper D., et al. Alternatives to Antibiotics—A Pipeline Portfolio Review. Lancet Infect. Dis. 2016;16:239–251. doi: 10.1016/S1473-3099(15)00466-1. - DOI - PubMed
    1. Machowska A., Stålsby Lundborg C. Drivers of Irrational Use of Antibiotics in Europe. Int. J. Environ. Res. Public Health. 2019;16:27. doi: 10.3390/ijerph16010027. - DOI - PMC - PubMed
    1. The World Medicines Situation 2011-Rational Use of Medicines. [(accessed on 16 February 2021)]; Available online: http://digicollection.org/hss/en/m/abstract/Js18064en/
    1. Innes G.K., Randad P.R., Korinek A., Davis M.F., Price L.B., So A.D., Heaney C.D. External Societal Costs of Antimicrobial Resistance in Humans Attributable to Antimicrobial Use in Livestock. Ann. Rev. Public Health. 2020;41:141–157. doi: 10.1146/annurev-publhealth-040218-043954. - DOI - PMC - PubMed
    1. WHO|Global Action Plan on Antimicrobial Resistance. [(accessed on 16 March 2021)]; Available online: http://www.who.int/antimicrobial-resistance/publications/global-action-p...